Sangamo Therapeutics to Release First Quarter 2025 Financial Results and Host Earnings Conference Call on May 12 Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a clinical-stage genomic medicine company developing transformative therapies using its proprietary platform technologies, announced today that it will…
Pacific Prime Thailand Honored with AXA Thailand’s 2025 Top International Broker Award In a significant recognition of its dedication to excellence and commitment to strategic partnerships, Pacific Prime Thailand has been awarded the prestigious Top International Broker Award by AXA…
Unlock Agility and Expertise with Oriola Advisory Services’ Interim Solutions In the highly regulated and rapidly evolving pharmaceutical and healthcare sectors, maintaining agility while ensuring access to expert support can be a significant challenge. Whether responding to sudden workforce changes,…
Ardent Health Reports First Quarter 2025 Financial Results Highlighting Revenue Growth and Strong Earnings Momentum Ardent Health Partners, Inc. (NYSE: ARDT), a premier healthcare provider serving rapidly expanding mid-sized urban markets across the United States, today announced its financial and…
Chemed Corporation to Present at the 2025 Bank of America Securities Health Care Conference Chemed Corporation (NYSE: CHE), a leading publicly traded company with two nationally recognized subsidiaries, today announced its participation in the upcoming Bank of America Securities 2025…
CVS Pharmacy: Bringing Personalized Care to Communities with New Small Format Stores In a rapidly evolving health care landscape, one thing remains constant: the importance of trusted, accessible, and personalized pharmacy care. CVS Pharmacy®, the largest retail pharmacy chain in…
Vasomune Therapeutics to Present Late-Breaking Research on AV-001 at the 2025 American Thoracic Society International Conference Vasomune Therapeutics Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to address diseases driven by vascular dysfunction, today announced its participation in the 2025…
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) reported robust financial and operational results for the first quarter of 2025, underscoring the company’s continued momentum and strategic focus on advancing its late-stage pipeline while reaffirming full-year revenue guidance. The company achieved a…
Fresenius Medical Care Achieves Strong Start to 2025 with Solid Organic Growth and Improved Profitability Across Segments Fresenius Medical Care, the world’s leading provider of products and services for individuals with chronic kidney failure, began 2025 with a strong operational…
World Ovarian Cancer Coalition Leads Global Campaign to Raise Awareness of Ovarian Cancer World Ovarian Cancer Day (WOCD) on May 8th stands as a pivotal moment in the ongoing global effort to raise awareness about ovarian cancer and to advocate…